Michael K. Porayko

机构：Vanderbilt University · ORCID：0000-0003-2862-9217

发表论文 105 篇 · 总被引 9257 次 · h-index 44

代表论文

• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial (2019 · The Lancet · 被引 1247)
• The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club (2003 · Hepatology · 被引 979)
• Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome (2021 · New England Journal of Medicine · 被引 467)
• Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1 (2016 · Gastroenterology · 被引 307)
• Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations (2012 · Hepatology · 被引 154)
• COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease (2019 · Journal of Pain and Symptom Management · 被引 60)